V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210037338 | 210008533 | 1.57 | 63 | Palliative (P) | 2018-01-22 | 2018-05-01 | FCR Oral - Cycle 2 onwards | N | N | 210015631 | FCR |
| 210037339 | 210008539 | 1.6 | 61 | Disease modification (D) | 2017-03-20 | 2017-04-20 | BENDAMUSTINE + RITUXIMAB | N | N | 210015667 | BENDAMUSTINE + RITUXIMAB |
| 210037340 | 210008545 | 1.58 | 40 | Curative (C) | 2017-10-10 | 2017-10-24 | VINCRISTINE | N | N | 210015677 | VINCRISTINE |
| 210037341 | 210026438 | 1.57 | 83.9 | Curative (C) | 2017-12-23 | 2017-12-23 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | N | 210015705 | FCR |
| 210037342 | 210019413 | null | 82 | Palliative (P) | 2017-12-23 | 2018-01-02 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | null | 210015709 | FCR |
| 210037344 | 210008595 | 1.71 | 75.3 | null | 2017-10-30 | 2018-08-17 | METHOTREXATE | 99 | N | 210015782 | METHOTREXATE |
| 210037345 | 210008601 | 1.69 | 64.3 | Curative (C) | 2017-07-01 | 2017-07-06 | Triple / Double Intrathecal Therapy | 2 | N | 210015788 | TRIPLE INTRATHECAL |
| 210037346 | 210008615 | 1.79 | null | Curative (C) | 2016-12-28 | 2017-04-03 | ALL UKALL60+ TRIAL | Y | N | 210015816 | UKALL60+ |
| 210037347 | 210008643 | null | 83.3 | Palliative (P) | 2015-05-24 | 2015-05-25 | ALL UKALL60+ TRIAL | N | N | 210015905 | UKALL60+ |
| 210037348 | 210008656 | 1.78 | null | Curative (C) | null | 2017-03-28 | ALL UKALL60+ TRIAL | N | N | 210015978 | UKALL60+ |
| 210037349 | 210019487 | 1.64 | 60.4 | null | 2016-05-17 | 2016-05-17 | IMATINIB | N | null | 210016088 | IMATINIB |
| 210037350 | 210008677 | 1.67 | 81 | Curative (C) | 2016-02-13 | 2016-10-07 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 210016120 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210037351 | 210019493 | 1.73 | 74.7 | Curative (C) | 2015-06-23 | 2016-01-02 | ALL UKALL2003 TRIAL | N | N | 210016143 | UKALL 2003 |
| 210037352 | 210019502 | 0 | 39.6 | Palliative (P) | 2013-11-20 | 2014-04-16 | R Chlorambucil | N | N | 210016177 | CHLORAMBUCIL + RITUXIMAB |
| 210037354 | 210008731 | 1.58 | 74.2 | Curative (C) | 2018-08-12 | 2018-10-23 | IDELALISIB + RITUXIMAB | Y | N | 210016258 | IDELALISIB + RITUXIMAB |
| 210037355 | 210008737 | 1.49 | 58 | Curative (C) | 2017-09-13 | 2017-12-06 | METHOTREXATE | Y | N | 210016266 | METHOTREXATE |
| 210037356 | 210030603 | 1.7 | 110.7 | Curative (C) | 2014-09-11 | 2014-12-05 | IMATINIB | null | Y | 210016287 | IMATINIB |
| 210037357 | 210008765 | null | null | Not known (9) | null | 2017-10-08 | ALL UKALL60+ TRIAL | N | N | 210016332 | UKALL60+ |
| 210037358 | 210008910 | 1.58 | 64.3 | Adjuvant (A) | 2016-01-22 | 2016-05-24 | ALL UKALL2003 TRIAL | Y | N | 210016886 | UKALL 2003 |
| 210037359 | 210008922 | null | 80 | Curative (C) | 2018-08-15 | 2018-08-16 | IMATINIB | 02 | N | 210016939 | IMATINIB |
| 210037360 | 210008945 | 1.82 | 74.4 | Palliative (P) | 2015-03-30 | 2015-03-30 | ALL UKALL60+ TRIAL | N | N | 210017034 | UKALL60+ |
| 210037361 | 210008973 | null | null | Curative (C) | 2017-11-06 | 2019-01-25 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 210017129 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 210037362 | 210008993 | null | 69.3 | Curative (C) | 2014-10-05 | 2015-02-09 | ALL Int GdeC EscCapMaint PhIII PAsp | N | N | 210017201 | ALL INTENSIFICATION |
| 210037363 | 210009037 | 1.86 | 69 | Curative (C) | 2017-06-09 | 2017-06-09 | Mercaptopurine | N | N | 210017421 | MERCAPTOPURINE |
| 210037364 | 210009041 | 1.8 | 60.4 | Palliative (P) | 2017-05-07 | 2017-05-13 | BLINATUMOMAB | 2 | N | 210017422 | BLINATUMOMAB |
| 210037365 | 210009046 | 0 | 26.8 | Curative (C) | 2015-07-12 | 2015-07-12 | FLAG + Idarubicin | Y | N | 210017447 | FLAG + IDARUBICIN |
| 210037366 | 210009053 | 1.86 | 88.6 | Curative (C) | 2017-04-08 | 2017-12-08 | ETOPOSIDE | N | N | 210017471 | ETOPOSIDE |
| 210037367 | 210009065 | null | 27.1 | Curative (C) | 2018-12-26 | 2019-01-08 | Chlorambucil | N | N | 210017486 | CHLORAMBUCIL |
| 210037368 | 210009071 | 1.67 | 86 | Curative (C) | 2014-09-23 | 2014-09-23 | Etoposide oral | N | N | 210017519 | ETOPOSIDE |
| 210037369 | 210009076 | 1.69 | 105.9 | Curative (C) | 2015-01-04 | 2015-01-07 | BLINATUMOMAB | N | null | 210017522 | BLINATUMOMAB |
| 210037370 | 210009118 | 1.85 | null | Disease modification (D) | 2015-01-10 | 2015-10-05 | Chlorambucil | N | N | 210017673 | CHLORAMBUCIL |
| 210037372 | 210009210 | 1.56 | 83 | Curative (C) | 2017-11-02 | 2017-11-07 | Blinatumomab | N | N | 210018045 | BLINATUMOMAB |
| 210037373 | 210009225 | null | 98 | Disease modification (D) | 2017-12-30 | 2018-11-27 | Venetoclax | 01 | N | 210018080 | VENETOCLAX |
| 210037374 | 210009267 | 1.81 | null | Curative (C) | 2016-12-09 | 2016-12-19 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 210018243 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 210037375 | 210009283 | 1.7 | 94.2 | Curative (C) | 2017-06-10 | 2017-06-10 | CHOP R - 21 days | null | N | 210018278 | CHOP R |
| 210037376 | 210009328 | 1.75 | 76.3 | Curative (C) | 2018-11-30 | 2019-01-21 | Alemtuzumab | 2 | N | 210018384 | ALEMTUZUMAB |
| 210037377 | 210030811 | null | 20 | null | 2017-11-05 | 2018-05-23 | ALL Int Gde A/B DInt PhIV pt1 PAsp | N | null | 210018518 | ALL INTENSIFICATION |
| 210037378 | 210009386 | null | 75 | Palliative (P) | 2018-01-11 | 2018-01-11 | CHOP R - 21 days | N | null | 210018557 | CHOP R |
| 210037379 | 210009396 | 1.79 | 46.8 | Curative (C) | 2017-04-24 | 2017-04-24 | ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp) | N | null | 210018579 | UKALLR3 |
| 210037380 | 210009436 | null | 10.7 | Curative (C) | 2017-02-16 | 2017-09-21 | Venetoclax | Y | N | 210018723 | VENETOCLAX |
| 210037382 | 210009735 | 1.77 | 113.8 | Disease modification (D) | 2017-09-03 | 2017-09-04 | Blinatumomab | 2 | N | 210019691 | BLINATUMOMAB |
| 210037383 | 210027040 | 1.68 | 76 | Curative (C) | 2020-03-24 | 2020-03-27 | CHOP R - 21 days | 99 | N | 210020804 | CHOP R |
| 210037384 | 210010145 | 1.83 | null | Curative (C) | 2016-05-10 | 2016-05-10 | Etoposide oral | N | Y | 210021185 | ETOPOSIDE |
| 210037385 | 210010191 | 1.72 | 69.3 | Curative (C) | 2019-08-20 | 2019-08-20 | MERCAPTOPURINE + METHOTREXATE | Y | N | 210021334 | MERCAPTOPURINE + METHOTREXATE |
| 210037386 | 210010197 | 1.79 | 0 | Palliative (P) | 2016-10-10 | 2017-05-13 | Etoposide Conditioning | Y | N | 210021343 | ETOPOSIDE |
| 210037387 | 210010255 | 1.6 | null | Disease modification (D) | 2015-01-24 | 2015-06-08 | Mercaptopurine | N | N | 210021606 | MERCAPTOPURINE |
| 210037388 | 210010304 | 1.85 | 100.4 | Curative (C) | 2016-07-19 | 2016-07-19 | Alemtuzumab | Y | null | 210021830 | ALEMTUZUMAB |
| 210037389 | 210010464 | null | 60 | Palliative (P) | 2019-06-16 | 2019-06-16 | Chlorambucil | N | N | 210023222 | CHLORAMBUCIL |
| 210037390 | 210010494 | 0 | 19.3 | Curative (C) | 2018-03-19 | 2018-03-19 | Mercaptopurine | N | N | 210023423 | MERCAPTOPURINE |
| 210037392 | 210010697 | 1.62 | 32.2 | Curative (C) | 2016-08-31 | 2016-08-31 | ALL Int Guide A/B/C Maint Ph V | 99 | null | 210025775 | ALL INTERIM GUIDELINES |